GyriCalc
Overview
GyriCalc, developed by NeuroSpectrum Insights, is an automated radiological image post-processing Software as a Medical Device (SaMD) designed to assist clinicians in evaluating pediatric brain structures. The tool is indicated for use with pediatric patients between 24 and 36 months of age.
The software processes magnetic resonance (MR) images to perform automated labeling, visualization, and quantification of segmentable brain structures. Key capabilities include:
- Automatic segmentation and labeling of over 14 functional brain regions.
- Volumetric, surface area, and cortical thickness measurements.
- Gyrification analysis, including calculation of the local gyrification index to measure cortical folding patterns.
- Generation of detailed, graphical morphometric reports and segmented images.
GyriCalc fits into clinical and diagnostic workflows by providing objective, quantitative brain biomarkers. It is designed to be operated by qualified technical personnel and interpreted by qualified clinicians, such as pediatric neurologists and radiologists, to support the early identification of structural markers associated with neurodevelopmental differences.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- Automated analysis of MRI images
- Identifies early structural markers of neurodevelopmental differences
- Assists in the diagnosis of autism
- Labels 14+ functional brain regions
- Measures cortical folding patterns
- Provides objective biomarkers
- Supports early detection in children as young as 2 years old
- Average accuracy rate of 92% (range 88-97%) in analyzing structural MRIs
- Web application for DICOM upload, processing, and clinical reporting
Use Cases
- Diagnosis of autism
- Early detection of neurodevelopmental conditions
- Objective measurement of brain structure in young children
- Supporting diagnostic decision making and care planning
- Potential future diagnosis of dyslexia, ADHD, and schizophrenia
What Physicians Need to Know
GyriCalc™ provides objective clarity through precise patient brain structure measurements, which can support early interventional therapies and potentially lead to better long-term quality-of-life patient outcomes. The technology is designed to assist in identifying neurologic and neurodevelopmental conditions in children between 24 and 36 months old.
Details
| Category | Neurology AI, Radiology & Imaging AI |
| Pricing | Unknown |
| Deployment | Web application (Django/React) for DICOM upload, processing, and clinical reporting |
| Compliance | |
| BAA Available | Unknown |
| HIPAA Compliant | Unknown |
| FDA Status | Cleared AI-estimated |
| Integrations | |
| EHR | Not specified |
| Specialties | Neurology, Pediatrics, Radiology |
FDA clearance history
This product’s FDA authorization. From FDA’s list of AI-enabled medical devices; each number links to FDA’s record.
| Decision date | Number | Name as listed by FDA |
| 2025-07-22 | K250686 510(k) | GyriCalc |
Ratings & Reviews
No reviews yet. Be the first to review this tool!
Rate GyriCalc
Videos
Product demos, reviews, and walkthroughs for GyriCalc.
Empowering Clinicians With Early, Objective Brain Insights | Introducing GyriCalcu2122 from NSI
NeuroSpectrum Insights





